Document x1BzQNNy9X13rqvMYRvqZDGd0

c Cr'V'. ' S 2*/ NATIONAL CANCER INSTITUTE MONOGRAPH 59 April 1982 Cancer Mortality in the United States: 1950--1977 NIH Publication No. 82-2435 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE NATIONAL INSTITUTES OF HEALTH NATIONAL CANCER INSTITUTE, BETHESDA, MARYLAND 20205 ' URL 05479 NATIONAL CANCER INSTITUTE MONOGRAPHS Vincent T. DeVita, Jr., Director, National Cancer Institute The Editorial Board welcomes proposals for the publication of monographs. However, the subject matter must be relevant!*-cancer research, have long-term interest, appeal to a wide readership, and be of quality meeting the standards of the Journal ofthe National Cancer Institute, Proposals should be sent to the Editor in Chief as early as possible, preferably several months before a conference (for conference proceedings) or before preparation of a final draft. Because the data presented in this volume will be widely used as a reference source, the Board of Editors has approved its publication as a logical sequel to our Monograph No. 33, "Patterns in Cancer Mortality in the United States: 1950-1967." BOARD OF EDITORS Peter Greenwald, Editor in Chief Elizabeth K. Weisburger, Assistant Editor in Chief Stuart A. Aaronaon, Associate Editor Charles H. Evans. Associate Editor Mary Fink, Associate Editor Janet W. Hartley, Associate Editor Donald Henson, Associate Editor Ronald B. Herberman, Associate Editor George S. Johnson, Associate Editor Kurt W. Kohn, Associate Editor Arthur S. Levine, Associate Editor John J. Mulvihill, Associate Editor Alan S. Rakson, Associate Editor Richard M. Simon, Associate Editor URL 05480- For sale ONLY by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C 20402. CANCER MORTALITY IN THE UNITED STATES: 1950-1977 URL 05481 Clinical Epidemiology Branch Field Studies and Statistics Program Division of Cancer Cause and Prevention Nationol Cancer Institute National Institutes of Health frank W. McKay Margot R. Hanson Robert W. Miller Foreword................................................................................. -.............................................. . Introduction ............ Methods ! ........ . AU Malignant Neoplasms....................-................................................................................... Lip .......................................................... .................................................................................. Salivary............................................................ ................ ....................................................... Floor of Mouth............ ................................................................ ..... ...................................... Oral Mesopharynx...... .......................................... ................................................................... Nasopharynx...--.................................................................................................................... . Hypopharynx............................................................................... ............................................. Pharynx Unspecified....................................................-........................................................... Buccal Cavity Plus Oral Pharynx...................................................................... ................... . Esophagus.......................................................................................... ....................................... Stomach.............................................................. .......................................... ........................... Small Intestine........................................................................................................................... Large Intestine.................................................................................................... ........ ....... ..... Rectum............. ......... ...... ........................................................................................................ Biliary Passages and Liver (Primary)...................................................................................... Pancreas ............ ..................................................................................................... ................. Peritoneum......................................................................... ...................................................... Now.......................................................................................................................................... Larynx.................. ..................................................................................................................... Bronchus, Trachea, and Lung..................................................................................... ........... Breast...................................................................................... .............................................. . Uterine Cervix........................................................................................................................... Body of Uterus.............................................................................. ............... .......... ................. Ovary, Uterine Tube, etc......................................................................................................... Prostate................................................................................................ .................................... Testis......................................................................................................................................... Kidney ............. .................................................................................................................... Bladder and Other Urinary Organs.................................................................. ....................... Melanoma........................................................................ ........................................................ . Skin........ ........... ....................................................................................................................... Eye............................................................................................................................................ t Nervous System....................................................................................................................... TTiyroid ................................................................................................................................... ' Bone......................................................................................................................................... Connective Tissue............................................................... .................................................... Hodgkin's Disease............................................................... .................................................... Non-Hodgkin's Lymphoma..................................................................................................... Multiple Myeloma.................................................................................................................... All Leukemia............................................................................................................................ Ail Mortality............................................................................................................................ Populations.............................................................................................................................. Appendix I--Annual Tumor Mortality by the 1CD......... ............................................ ..........................Appendix 11--Sixth, Seventh, and Eighth Revisions of the ICD for Cancer..... ............................. .... Appendix III--Accuracy of Cancer Death Certificates and its Effect on Cancer Mortality Statistics. iii v 2 12 18 24 30 36 42 48 54 60 70 80 90 96 106 116 126 136 142 148 154 164 C. XI--5 174 180 184 * 190 CO tn> 196 202 212 222 232 238 244 254 260 270 280 290 300 310 320 330 340 450 467 Bladder and Other Urinary Glands Age-adjusted Mortality Rates h + *HHITE HALES KbHHITE FEMALES sNONWHJTE MIES QbNONHHITE FEMALES URL 05483 u ^..... ............................................................................................ ^60 1955 I960 1965 CALENDAR YEARS 1970 1975 1950 1953 1955 1955 1957 1955 1959 1950 1951 1952 1953 1955 1955 1955 1957 1955 1959 1970 1971 1972 1973 1975 1975 1975 1977 mn III!-- -- C7"02 ADJ. 5 or turn UTI Mil flftUO* 101 5339 535 597 *597 787 750 5080 5039 5203 5281 5115 5187 53*2 557* 5831 5579 5880 5855 39*2 8009 8152 8225 5309 839 8.05 8. 21 5. 20 8.29 8. 29 8.30 5.33 5. 19 8. 33 8.B1 8.25 8.39 8.0 8.12 5.1* 8.27 8. *8 8.50 8.39 8.55 8. 38 8.50 8.59 8.12 5.85 5.91 8.92 7.33 7.28 7.0 7.33 7.31 7.3$ 7.3* 7.17 7.3J 7.36 7.17 7.Z8 7.38 7.05 7.02 7.21 7.37 7. *0 7.22 7.50 7. IS 7.37 7. *1 7.*9 7.*5 7. *3 7.36 38 30 30 22 2* 1* 10 09 05 09 * 07 3 93 3 98 3 95 3 79 3 70 3 70 3 02 3 79 3 70 3 81 3 59 3 58 3 59 3 57 3 88 3 80 3 S* ---- hits iriAis-- TOTJkl oods AOJ. % or SttTIS UTS UTS use* -on x* III-- TOTAL cross AM. i or SSATlI tits UTS mss* TOTAL StATBS 1071 1989 1971 2 010 2000 212 2070 2137 2079 2127 2158 2195 2233 2255 2227 2390 227* 2005 2315 2377 258* 2M 1200 2529 2591 2532 2881 2793 2.75 2.73 2.90 2.81 2.75 2* 97 2.7 2.79 2.58 2.58 2.87 2.87 2.88 2. 87 2.80 3.75 2.59 2.71 2.59 2.53 2.90 2. 85 2.80 2.70 2.75 2. 87 2.01 2.91 3.05 3. 02 3.03 3.01 2.09 2.97 3.82 3.92 3.88 3.63 3.60 3.57 3. 58 3.50 2.0 3.51 3.31 3. 30 3.23 3.33 3. 33 3. 16 3.08 3.13 3. 13 3.02 3.00 3.13 2.09 2.09 2.09 2.09 3.09 2.11 2.02 3.03 1.96 1.96 1.9* 1.93 1.91 1.09 1.93 1.91 1.77 1.92 1.71 1.71 1.79 1.66 1.59 1.6 1.63 1.55 1.57 1.59 1 | | 1 | 1 I 1 1 1 | | | 1 1 i | 1 | I t | | 1 | I | t 2*9 3.30 93 1.27 | 179 272 3.2 5.0 3.32 | >62 361 3.39 8.91 3.10 | 173 293 3. 1 5. 0* 3.12 ( 207 390 3.81 5.08 2.98 | 205 360 3.99 .2 2.62 | 173 302 3.39 X 15 2.99 1 207 338 3.57 S. 23 3.97 | 236 32* 3.5 5.11 2.97 | 226 3* 3.59 5.29 2.92 1 225 360 3.59 5.28 2.77 | 289 178 3. 85 5. 39 2.79 | 225 373 3. 5.22 2.67 i 273 07 3.79 5.87 2.76 | 246 375 3.2 .98 2.*5 | 286 399 3.57 5.31 2.39 1 2*3 38 3. 92 5.95 2.72 | *73 S 3.9* 3.73 2.82 | 337 2 3.75 5.62 2.49 | 287 73 X 95 6.02 2.8* | 291 77 X 91 5.90 2.58 l 205 79 3.98 5.82 2.53 j 303 2*9 3.91 5.91 2.51 < 172 71 3.95 5.55 2.29 | 326 99 3.73 5.39 2.26 | 335 55 3.87 5.21 2.10 | 339 535 3.92 5.79 2.29 | }U 517 X 72 5.63 2.18 | 349 cross tATS 2.21 1.96 2.0 3.39 2.20 1.90 2.21 2.46 2.29 2.22 2.5* 2.07 2.as 2. 16 2.20 2.39 2.24 2.71 2.27 2. 19 2. 16 2. 25 2.50 2.33 2.35 2.33 2.29 2.30 'Age-adjusted rate as percent of age-adjusted rate for all malignant neoplasms. ASJ. 5 or OATS It ALIO* 3.16 2.8* X02 3.43 3.3* 2.79 X04 3.*9 3.18 x to 3.5* 2.90 3.43 3.0 1 3. 17 3.28 3.10 3.6 X02 2.92 2.96 2.9* 3.2* 3.00 3.03 2.95 X 96 2.83 2 . to 1.97 2. 09 2.0 1.96 2.09 2.62 2.20 2.22 2.45 3.02 2.as 2. 16 2. 25 2.32 2. 17 2.56 3. 11 3.07 2.08 2.05 3. 39 3.0* 3.09 3.06 1.91 Includes: Bladder, urachus, urethra, and other urinary organs (NOS). (ICO 161 (6th]; ICO 191-161.8 [7th}; ICO 196,199.9 (8th]> 212 i, >' .fc'-v .X \ * -. V- h \,-(wr. NATIONAL CANCER INSTITUTE MONOGRAPH NO. 59 Bladder and Other Urinary Glands Age-specific Rates White Males White Females URL 05484 Nonwhite Males Nonwhite Females COLE P: Lower urinary tract. In Cancer Epidemiology end Prevention: Current Concepts (Schottenfeld D, ed). Springfield, III: Charles C Thomas, 1975, pp 235-262 CANCER MORTALITY IN THE U.S., 1950-1977 213 Kidney Age-adjusted Mortality Rates c 33 o s0<j3y itso t HI 1952 1H) 1* 1955 1*56 1*57 1 *SS 1*5* 1*50 1961 1962 1963 196* 1965 1 966 1967 1966 1969 1970 1971 1972 1973 1976 1975 1976 1977 --------- tltltt mt-- ... TOTAL CHOP* 6DJ. % or tuns UTI a it i siiie> ..... 9IXTK KIUK90961 CI0B1 IN. 0 OP Btt9M 1*7* 1691 66610* -09*36 611--*-- TOT6L C30DS 6DJ. t or 036909 691 2693 ui:* ...----------otin mm.. 90961 COOOB 6DJ. I OP 006906 0691 6TB 1 6110* 2126 2157 23 17 23* 1 2*53 2551 26 2 6 2720 3761 3*75 29*6 20*3 3015 3219 3250 3266 3657 3*01 3577 36*1 3701 3790 1961 3619 025 399* *066 *23* 3. 1* 3. U 3.32 3. 37 3. *0 3. *6 3. 53 3.59 3.60 3.66 3.72 1.79 3.70 3. 90 3.69 3.67 * .06 3.96 *. 13 *. 17 *.20 . 27 *.39 6.25 *. *6 *.*0 *. *6 *. 61 3.37 3.3* 3.5* 3. 56 3.60 3.66 3.1* 3.60 3.79 3.91 3.93 *.03 3.93 *. 17 *. 15 *. 13 6.36 6.3* .2 6.*7 .S0 6.56 6.67 .*9 9.66 *.56 *.63 6.7* 2.01 1.59 2.06 2.05 2.06 2.06 2.09 2.11 2.1* 2.19 2.17 2.21 2.15 2.2* 2.23 2.16 2.26 2.20 2.27 2.29 2.26 2.29 2.32 2.23 2.29 2.25 2.2* 2.26 | I ) I | 1 | 1 | I | | | 1 1 1 | | | | | ( | | ( | | | 1310 1336 1377 1396 1*66 1561 15*4 1653 1666 1666 1669 1602 1621 1S3 1693 1961 2006 3066 3079 2109 3166 2135 1066 32*6 3369 3*57 3*67 3567 1.92 1.93 1.96 1.95 2.01 2.11 2.05 2.15 3. l* 2. 10 2.07 2.20 3.16 3.16 2.21 3.36 2.26 3.31 3.32 2.32 3.37 2.31 2.3* 3.40 2.53 2.59 2.59 3.70 3.00 1. 99 1.99 1.97 3.03 3. 09 3.01 3.10 3.07 2.03 1.97 2.06 2.06 2.0* 2.06 2.11 3.09 2.06 2.00 2.00 3.06 3.01 2.02 3.0* 3.13 3.16 3.11 3.16 1.37 1.37 1.37 1.37 1. *3 1. *9 1.** 1.51 1.52 1.50 l. 7 1.56 1.55 1.5* 1.57 1.60 1.59 1.50 1.59 1.59 1.59 1.55 1.55 1.57 1.61 1.65 1.60 1.6* | | | | | | | t | 1 1 | | 1 | 1 | 1 | | | 1 | | | 1 1 | 120 117 1*5 135 155 1*5 169 190 301 190 199 226 236 215 252 2*3 22* 293 315 276 396 267 163 201 309 130 353 5*1 1.5* 1.*? 1.79 1.63 1.02 1.67 1.90 2. 00 3. IS 1.90 1.96 2.21 2.17 3.00 2.30 3.16 2.05 2.52 2.67 3.33 3.3 3.31 2.57 2.32 2.35 2. *6 2.50 2.*5 1.91 1.05 2.2* 1.9* 2.22 2.06 3.36 3.61 2.73 3.63 3.5* 3.57 2.0* 2.55 3.04 2.91 3.00 2.41 3.55 3.1* 3.39 3.22 3.55 3.23 9.2* 3. *2 3.59 3.27 1.24 1.33 1.42 1.23 1.30 1.33 1.33 1.43 1.53 1.*0 1.36 1.40 1.46 1.2* 1.50 1.41 1.30 1.56 1.62 1.40 1. *7 1.40 1.55 1.33 1.31 1.30 1.*0 1.31 | | 1 | 1 | ( 1 | | | | | | I | | | 1 | | | | I i I I | 09 7 90 90 6 *1 111 9* 113 130 125 1*0 15* 117 137 1*5 146 155 146 M0 160 161 09 173 176 193 209 311 1. 10 1.05 1.04 1.0* 0.99 1.00 1.19 1.02 1.15 1. 16 1. 16 1.39 1.36 1.03 1.1* 1.22 1.30 1.25 1.15 1.30 1.21 1.3* 1.39 1.3* 1.23 1.33 1.41 1.39 1.3* 1.23 1.37 1.26 1.23 1.2* 1.40 1.26 1.36 1.36 1. *6 1.61 1.45 1. 26 1.43 1.50 1.51 1.53 1.40 1.59 1.46 1.6 1 1.56 1.52 1.62 1.61 1.70 1.67 0.90 o.as 0. 95 0. 90 0.66 0.67 0.96 0.67 0.9* 0.99 1.01 1. 12 1.17 0.93 1.03 1.06 1.05 1.07 0. 96 1. 13 1.05 1. 12 1. 11 1.03 1.05 1. 13 1. 16 1. 13 * Age-adjusted rate a* percent of age-adjusted rate for alt malignant neoplasms. Includes: Kidney and ureter. (ICO ISO [6th], fCD 160 (tthj; ICO 189-188.2 [ftthS 202 NATIONAL CANCER INSTTTUTE MONOGRAPH NO. SO .Kidney Agespeciflc Rates White Males White Females Nonwhite Males Nonwhite Females BLOT WJ, Praumeni JF JR: Geographic pattern* of renal cancer in the United States. JNCI 63:363-366,1979 CANCER MORTALITY IN THE U.S., 1950-1977 203